You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer

Citation Tools

Article menu
Download PDFPDF
ABSTRACT: Free Communications: Cervical Cancer - Sunday, October 15, 2006
0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Thomas GM, Ali S, Patel M, et al
0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer
International Journal of Gynecologic Cancer 2006;16:603-604.